The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.
Open accessAbstract
Approximately half of hepatocellular carcinoma (HCC) from regions in the world with high contamination of food with the mycotoxin aflatoxin B1 (AFB1) contain a mutation in codon 249 of the p53 tumor suppressor gene. The mutation almost exclusively consists of a G-->T transversion in the third position of this codon, resulting in the insertion of serine at position 249 in the mutant protein. To gain insight into the mechanism of formation of this striking mutational hot spot in hepatocarcinogenesis, we studied the mutagenesis of codons 247-250 of p53 by rat liver microsome-activated AFB1 in human HCC cells HepG2 by restriction fragment length polymorphism/polymerase chain reaction genotypic analysis. AFB1 preferentially induced the transversion of G-->T in the third position of codon 249. However, AFB1 also induced G-->T and C-->A transversions into adjacent codons, albeit at lower frequencies. Since the latter mutations are not observed in HCC it follows that both mutability on the DNA level and altered function of the mutant serine 249 p53 protein are responsible for the observed mutational hot spot in p53 in HCC from AFB1-contaminated areas. Our results are in agreement with an etiological role of AFB1 in hepatocarcinogenesis in regions of the world with AFB1-contaminated food.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
MUTAGENESIS BY APURINIC/APYRIMIDINIC SITES
Loeb, L. A., & Preston, B. D. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.001221 · Cited by 901
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J.-M., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes
Rideout, W. M., Coetzee, G. A., Olumi, A. F., & Jones, P. A. (1990) · Science · doi:10.1126/science.1697983 · Cited by 640
High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus
Lundberg, K. S., Shoemaker, D. D., Adams, M. W. W., Short, J. M., Sorge, J. A., & Mathur, E. J. (1991) · Gene · doi:10.1016/0378-1119(91)90480-y · Cited by 577
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase
Eckert, K. A., & Kunkel, T. A. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.13.3739 · Cited by 401
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami, Y., Hayashi, K., Hirohashi, S., & Sekiya, T. (1991) · PubMed · Cited by 374
Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei
Van Rensburg, S. J., Cook-Mozaffari, P., Van Schalkwyk, D. J., Van der Watt, J. J., Vincent, T. J., & Purchase, I. F. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.107 · Cited by 330
Characterization of the human p53 gene.
Lamb, P., & Crawford, L. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1379 · Cited by 327
Sagher, D., & Strauss, B. (1983) · Biochemistry · doi:10.1021/bi00288a026 · Cited by 320
Base substitution mutations induced by metabolically activated aflatoxin B1.
Foster, P. L., Eisenstadt, E., & Miller, J. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2695 · Cited by 274
Puisieux, A., Lim, S.-K., Groopman, J. D., & Öztürk, M. (1991) · PubMed · Cited by 259
p53 gene mutation spectrum in hepatocellular carcinoma.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., & Hirohashi, S. (1992) · PubMed · Cited by 250
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.
Yeh, F. S., Yuan, J., Mo, C.-C., Luo, S., Tong, M. J., & Henderson, B. E. (1989) · PubMed · Cited by 201
Scorsone, K. A., Zhou, Y. Z., Butel, J. S., & Slagle, B. L. (1992) · PubMed · Cited by 162
In vitro reactions of aflatoxin B1-adducted DNA.
Groopman, J. D., Croy, R. G., & Wogan, G. N. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5445 · Cited by 139
Sequence specificity in aflatoxin B1--DNA interactions.
Muench, K. F., Misra, R. P., & Humayun, M. Z. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.6 · Cited by 122
Yang, J., Maher, V. M., & McCormick, J. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3787 · Cited by 112
Levy, D. D., Groopman, J. D., Lim, S. E., Seidman, M. M., & Kraemer, K. H. (1992) · Cancer Research · Cited by 92
Genotypic mutation analysis by RFLP/PCR
Pourzand, C., & Cerutti, P. (1993) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(93)90213-y · Cited by 92
Self-citationp53 Mutations in human hepatocellular carcinomas from Germany.
Kress, S., Jahn, U.-R., Buchmann, A., Bannasch, P., & Schwarz, M. (1992) · PubMed · Cited by 88
A genotypic mutation system measuring mutations in restriction recognition sequences
Felley‐Bosco, E., Pourzand, C., Zijlstra, J., Amstad, P., & Cerutti, P. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.11.2913 · Cited by 59
Self-citationMarkers of Exposure to Carcinogens
Wogan, G. N. (1989) · Environmental Health Perspectives · doi:10.1289/ehp.89819 · Cited by 56
Chiocca, S., Sandy, M. S., & Cerutti, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5331 · Cited by 31
Self-citation
Cited by
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
“In addition, the same base pair has been shown to be a hot spot for mutation by aflatoxin in hepatocytes in vitro [168] and to be more frequently mutated in nontumorous liver tissue of patients originating from supposed high aflatoxin exposure regions than those from low exposure regions [169].”
BackgroundHussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690
Self-citationMolecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Clinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Metadata
- Authors
- Aguilar, F., Hussain, S. P., & Cerutti, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-09-15
- Volume
- 90
- Issue
- 18
- Pages
- 8586-8590
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1973368924
- Cited by
- 489
- References
- 27
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.